Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy
Takanori Kiyotoki(Okayama University), Hisashi Masuyama(Okayama University), Takeshi Nishida(Osaka Prefectural Medical Center), Masayuki Saijo(Okayama University), Naoyuki Ida(Okayama University), Keiichiro Nakamura, Junko Haraga(Okayama University), Tomoyuki Kusumoto(Okayama University), Chiaki Omichi(Okayama University)
Cited by 43
Related Papers
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
|Journal of Infection and Chemotherapy|2012|325
Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study
|Journal of Infection and Chemotherapy|2013|96
Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives
|Journal of Clinical Medicine|2021|91
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79